Clinical trials
Phase 2 Cardiomyopathy, Hypertrophic trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2012 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Array Biopharma, now a wholly owned subsidiary of Pfizer | 1 |
| Imbria Pharmaceuticals, Inc. | 1 |
| Manchester University NHS Foundation Trust | 1 |
| Newcastle University | 1 |
| Novartis Pharmaceuticals | 1 |
| Rocket Pharmaceuticals Inc. | 1 |
| University College, London | 1 |
| University Hospital Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 8 |
| Cardiomegaly | 1 |
| Cardiomyopathies | 1 |
| Glycogen Storage Disease Type IIb | 1 |
| Hypertrophy, Left Ventricular | 1 |
| Lysosomal Storage Diseases | 1 |
| Noonan Syndrome | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.